222 related articles for article (PubMed ID: 22347506)
1. ALK-activating homologous mutations in LTK induce cellular transformation.
Roll JD; Reuther GW
PLoS One; 2012; 7(2):e31733. PubMed ID: 22347506
[TBL] [Abstract][Full Text] [Related]
2. Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.
Reshetnyak AV; Murray PB; Shi X; Mo ES; Mohanty J; Tome F; Bai H; Gunel M; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15862-7. PubMed ID: 26630010
[TBL] [Abstract][Full Text] [Related]
3. Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.
Montavon G; Jauquier N; Coulon A; Peuchmaur M; Flahaut M; Bourloud KB; Yan P; Delattre O; Sommer L; Joseph JM; Janoueix-Lerosey I; Gross N; Mühlethaler-Mottet A
Oncotarget; 2014 Jun; 5(12):4452-66. PubMed ID: 24947326
[TBL] [Abstract][Full Text] [Related]
4. An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway.
Ueno H; Hirano N; Kozutsumi H; Sasaki K; Tanaka T; Yazaki Y; Hirai H
J Biol Chem; 1995 Aug; 270(34):20135-42. PubMed ID: 7650032
[TBL] [Abstract][Full Text] [Related]
5. ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells.
Fadeev A; Mendoza-Garcia P; Irion U; Guan J; Pfeifer K; Wiessner S; Serluca F; Singh AP; Nüsslein-Volhard C; Palmer RH
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E630-E638. PubMed ID: 29317532
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.
Murugan AK; Xing M
Cancer Res; 2011 Jul; 71(13):4403-11. PubMed ID: 21596819
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants.
McDuff FK; Lim SV; Dalbay M; Turner SD
Mol Carcinog; 2013 Jan; 52(1):79-83. PubMed ID: 22086496
[TBL] [Abstract][Full Text] [Related]
8. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
Guan J; Umapathy G; Yamazaki Y; Wolfstetter G; Mendoza P; Pfeifer K; Mohammed A; Hugosson F; Zhang H; Hsu AW; Halenbeck R; Hallberg B; Palmer RH
Elife; 2015 Sep; 4():e09811. PubMed ID: 26418745
[TBL] [Abstract][Full Text] [Related]
9. Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684.
Schönherr C; Ruuth K; Yamazaki Y; Eriksson T; Christensen J; Palmer RH; Hallberg B
Biochem J; 2011 Dec; 440(3):405-13. PubMed ID: 21838707
[TBL] [Abstract][Full Text] [Related]
10. Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α).
Reshetnyak AV; Mohanty J; Tomé F; Puleo DE; Plotnikov AN; Ahmed M; Kaur N; Poliakov A; Cinnaiyan AM; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):8340-8345. PubMed ID: 30061385
[TBL] [Abstract][Full Text] [Related]
11. Expression of a chimeric CSF1R-LTK mediates ligand-dependent neurite outgrowth.
Yamada S; Nomura T; Takano K; Fujita S; Miyake M; Miyake J
Neuroreport; 2008 Nov; 19(17):1733-8. PubMed ID: 18849880
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis.
Weiss JB; Xue C; Benice T; Xue L; Morris SW; Raber J
Pharmacol Biochem Behav; 2012 Jan; 100(3):566-74. PubMed ID: 22079349
[TBL] [Abstract][Full Text] [Related]
13. The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase.
Ueno H; Honda H; Nakamoto T; Yamagata T; Sasaki K; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Oncogene; 1997 Jun; 14(25):3067-72. PubMed ID: 9223670
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of cytokine-mediated activation of ALK family receptors.
De Munck S; Provost M; Kurikawa M; Omori I; Mukohyama J; Felix J; Bloch Y; Abdel-Wahab O; Bazan JF; Yoshimi A; Savvides SN
Nature; 2021 Dec; 600(7887):143-147. PubMed ID: 34646012
[TBL] [Abstract][Full Text] [Related]
15. LTK and ALK promote neuronal polarity and cortical migration by inhibiting IGF1R activity.
Christova T; Ho SK; Liu Y; Gill M; Attisano L
EMBO Rep; 2023 Jul; 24(7):e56937. PubMed ID: 37291945
[TBL] [Abstract][Full Text] [Related]
16. Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk.
Mo ES; Cheng Q; Reshetnyak AV; Schlessinger J; Nicoli S
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12027-12032. PubMed ID: 29078341
[TBL] [Abstract][Full Text] [Related]
17. Molecular Modeling for Structural Insights Concerning the Activation Mechanisms of F1174L and R1275Q Mutations on Anaplastic Lymphoma Kinase.
Jiang CH; Huang CX; Chen YJ; Chuang YC; Huang BY; Yang CN
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004444
[TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
Werner MT; Zhao C; Zhang Q; Wasik MA
Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
[TBL] [Abstract][Full Text] [Related]
19. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition.
Roskoski R
Pharmacol Res; 2013 Feb; 68(1):68-94. PubMed ID: 23201355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
